117 related articles for article (PubMed ID: 23329453)
21. Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dot-based microfluidic protein chip.
Hu M; Yan J; He Y; Lu H; Weng L; Song S; Fan C; Wang L
ACS Nano; 2010 Jan; 4(1):488-94. PubMed ID: 20041634
[TBL] [Abstract][Full Text] [Related]
22. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.
Kuo SJ; Wang BB; Chang CS; Chen TH; Yeh KT; Lee DJ; Yin PL; Chen M
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):146-51. PubMed ID: 17638622
[TBL] [Abstract][Full Text] [Related]
23. World-to-chip microfluidic interface with built-in valves for multichamber chip-based PCR assays.
Oh KW; Park C; Namkoong K; Kim J; Ock KS; Kim S; Kim YA; Cho YK; Ko C
Lab Chip; 2005 Aug; 5(8):845-50. PubMed ID: 16027935
[TBL] [Abstract][Full Text] [Related]
24. A digital microfluidic method for multiplexed cell-based apoptosis assays.
Bogojevic D; Chamberlain MD; Barbulovic-Nad I; Wheeler AR
Lab Chip; 2012 Feb; 12(3):627-34. PubMed ID: 22159547
[TBL] [Abstract][Full Text] [Related]
25. Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer.
Mengel M; Hebel K; Kreipe H; von Wasielewski R
Breast J; 2005; 11(1):34-40. PubMed ID: 15647076
[TBL] [Abstract][Full Text] [Related]
26. HER2 status in breast cancer determined by IHC and FISH: comparison of the results.
Mrozkowiak A; Olszewski WP; Piaścik A; Olszewski WT
Pol J Pathol; 2004; 55(4):165-71. PubMed ID: 15757204
[TBL] [Abstract][Full Text] [Related]
27. 3D origami-based multifunction-integrated immunodevice: low-cost and multiplexed sandwich chemiluminescence immunoassay on microfluidic paper-based analytical device.
Ge L; Wang S; Song X; Ge S; Yu J
Lab Chip; 2012 Sep; 12(17):3150-8. PubMed ID: 22763468
[TBL] [Abstract][Full Text] [Related]
28. Cell-based sensor for analysis of EGFR biomarker expression in oral cancer.
Weigum SE; Floriano PN; Christodoulides N; McDevitt JT
Lab Chip; 2007 Aug; 7(8):995-1003. PubMed ID: 17653341
[TBL] [Abstract][Full Text] [Related]
29. Automatic single cell segmentation on highly multiplexed tissue images.
Schüffler PJ; Schapiro D; Giesen C; Wang HA; Bodenmiller B; Buhmann JM
Cytometry A; 2015 Oct; 87(10):936-42. PubMed ID: 26147066
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic liquid chromatography system for proteomic applications and biomarker screening.
Lazar IM; Trisiripisal P; Sarvaiya HA
Anal Chem; 2006 Aug; 78(15):5513-24. PubMed ID: 16878890
[TBL] [Abstract][Full Text] [Related]
31. An integrated microfluidic culture device for quantitative analysis of human embryonic stem cells.
Kamei K; Guo S; Yu ZT; Takahashi H; Gschweng E; Suh C; Wang X; Tang J; McLaughlin J; Witte ON; Lee KB; Tseng HR
Lab Chip; 2009 Feb; 9(4):555-63. PubMed ID: 19190791
[TBL] [Abstract][Full Text] [Related]
32. Prevention of air bubble formation in a microfluidic perfusion cell culture system using a microscale bubble trap.
Sung JH; Shuler ML
Biomed Microdevices; 2009 Aug; 11(4):731-8. PubMed ID: 19212816
[TBL] [Abstract][Full Text] [Related]
33. Development of an open stand-alone platform for regenerable automated microarrays.
Kloth K; Niessner R; Seidel M
Biosens Bioelectron; 2009 Mar; 24(7):2106-12. PubMed ID: 19110413
[TBL] [Abstract][Full Text] [Related]
34. Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections.
Brajkovic S; Dupouy DG; de Leval L; Gijs MA
Lab Invest; 2017 Aug; 97(8):983-991. PubMed ID: 28553936
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer HER2 equivocal cases: is there an alternative to FISH testing? A pilot study using two different antibodies sequentially.
Yosepovich A; Avivi C; Bar J; Polak-Charcon S; Mardoukh C; Barshack I
Isr Med Assoc J; 2010 Jun; 12(6):353-6. PubMed ID: 20928989
[TBL] [Abstract][Full Text] [Related]
36. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
Dressler LG; Berry DA; Broadwater G; Cowan D; Cox K; Griffin S; Miller A; Tse J; Novotny D; Persons DL; Barcos M; Henderson IC; Liu ET; Thor A; Budman D; Muss H; Norton L; Hayes DF
J Clin Oncol; 2005 Jul; 23(19):4287-97. PubMed ID: 15994142
[TBL] [Abstract][Full Text] [Related]
37. A touch-and-go lipid wrapping technique in microfluidic channels for rapid fabrication of multifunctional envelope-type gene delivery nanodevices.
Kitazoe K; Wang J; Kaji N; Okamoto Y; Tokeshi M; Kogure K; Harashima H; Baba Y
Lab Chip; 2011 Oct; 11(19):3256-62. PubMed ID: 21829858
[TBL] [Abstract][Full Text] [Related]
38. Integrated microfluidic biochips for DNA microarray analysis.
Liu RH; Dill K; Fuji HS; McShea A
Expert Rev Mol Diagn; 2006 Mar; 6(2):253-61. PubMed ID: 16512784
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
[TBL] [Abstract][Full Text] [Related]
40. Development of a quantitative diagnostic method of estrogen receptor expression levels by immunohistochemistry using organic fluorescent material-assembled nanoparticles.
Gonda K; Miyashita M; Watanabe M; Takahashi Y; Goda H; Okada H; Nakano Y; Tada H; Amari M; Ohuchi N
Biochem Biophys Res Commun; 2012 Sep; 426(3):409-14. PubMed ID: 22959769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
